scholarly journals Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer

Oncotarget ◽  
2017 ◽  
Vol 8 (26) ◽  
pp. 43080-43090 ◽  
Author(s):  
Ju Yang ◽  
Ting Xu ◽  
Daniel R. Gomez ◽  
Xianglin Yuan ◽  
Quynh-Nhu Nguyen ◽  
...  
BMC Cancer ◽  
2019 ◽  
Vol 19 (1) ◽  
Author(s):  
Kuniaki Katsui ◽  
Takeshi Ogata ◽  
Kenta Watanabe ◽  
Norihisa Katayama ◽  
Junichi Soh ◽  
...  

Abstract Background The relationship between lung dose-volume histogram (DVH) parameters and radiation pneumonitis (RP) associated with induction concurrent chemoradiotherapy (CCRT) followed by surgery in patients with non-small cell lung cancer (NSCLC) is unclear, particularly when concerning irradiation of the whole lung prior to resection. We performed this study to identify factors associated with grade ≥ 2 RP in such patients. Methods Patients who received induction CCRT (chemotherapy: cisplatin and docetaxel; radiotherapy: 46 Gy/23 fractions) between May 2003 and May 2017 were reviewed. The mean lung dose (MLD) and the percentage of the lung volume that received ≥5 Gy (V5) and ≥ 20 Gy (V20) were calculated. Factors associated with the development of grade ≥ 2 RP were analyzed. Results One hundred and eight patients were included in this study, 34 (31.5%) of whom experienced grade ≥ 2 RP. A V20 ≥ 21%, an MLD ≥10 Gy, and a lower lobe tumor location were significant predictors of grade ≥ 2 RP on univariate analysis (p = 0.007, 0.002, and 0.004, respectively). Moreover, an MLD ≥10 Gy and lower lobe location were significant predictors of grade ≥ 2 RP on multivariate analysis (p = 0.026 and 0.0043, respectively). The cumulative incidence rates of grade ≥ 2 RP at 6 months were 15.7 and 45.6% in patients with MLDs < 10 Gy and ≥ 10 Gy, respectively, and were 23.5 and 55.6% in patients with upper/middle lobe- vs. lower lobe-located tumors, respectively. Conclusions MLD and lower lobe location were predictors of grade ≥ 2 RP in patients who received induction CCRT. It is necessary to reduce the MLD to the greatest extent possible to prevent the occurrence of this adverse event.


2021 ◽  
Vol 11 (1) ◽  
Author(s):  
Daisuke Kawahara ◽  
Nobuki Imano ◽  
Riku Nishioka ◽  
Kouta Ogawa ◽  
Tomoki Kimura ◽  
...  

AbstractTo predict grade ≥ 2 radiation pneumonitis (RP) in patients with locally advanced non-small cell lung cancer (NSCLC) using multi-region radiomics analysis. Data from 77 patients with NSCLC who underwent definitive radiotherapy between 2008 and 2018 were analyzed. Radiomic feature extraction from the whole lung (whole-lung radiomics analysis) and imaging- and dosimetric-based segmentation (multi-region radiomics analysis) were performed. Patients with RP grade ≥ 2 or < 2 were classified. Predictors were selected with least absolute shrinkage and selection operator logistic regression and the model was built with neural network classifiers. A total of 49,383 radiomics features per patient image were extracted from the radiotherapy planning computed tomography. We identified 4 features and 13 radiomics features in the whole-lung and multi-region radiomics analysis for classification, respectively. The accuracy and area under the curve (AUC) without the synthetic minority over-sampling technique (SMOTE) were 60.8%, and 0.62 for whole-lung and 80.1%, and 0.84 for multi-region radiomics analysis. These were improved 1.7% for whole-lung and 2.1% for multi-region radiomics analysis with the SMOTE. The developed multi-region radiomics analysis can help predict grade ≥ 2 RP. The radiomics features in the median- and high-dose regions, and the local intensity roughness and variation were important factors in predicting grade ≥ 2 RP.


2021 ◽  
Author(s):  
Daisuke Kawahara ◽  
Nobuki Imano ◽  
Riku Nishioka ◽  
Kouta Ogawa ◽  
Tomoki Kimura ◽  
...  

Abstract Objective To predict grade 2 radiation pneumonitis (RP) in locally advanced non-small cell lung cancer (NSCLC) patients with high accuracy by using multi-region radiomics analysis.Material and Methods Data from 77 patients with NSCLC who underwent definitive radiotherapy from 2008 to 2018 were analyzed. Radiomic feature extraction from the whole lung (whole-lung radiomics analysis) and imaging- and dosimetric-based segmentation (multi-region radiomics analysis) were performed. The data were split into 2 sets: 54 tumors for model training and 23 tumors for model testing. Patients with RP grade ≥2 or RP grade <2 was classified. Models were built with least absolute shrinkage and selection operator logistic regression and applied to the set of candidate predictors. To build predictive models with clinical features, machine-learning methods with neural network classifiers were used. The precision, accuracy, and sensitivity by generating confusion matrices and the areas under the receiver operating characteristic curve (AUC) for each model were evaluated. Results A total of 49383 radiomics features per patient image were extracted from the radiotherapy planning computed tomography scan. We identified 4 features selected in the whole-lung radiomics analysis and 13 radiomics features selected in the multi-region radiomics analysis for the classification. Out of 13 features, the median and high-dose region were selected from the shape analysis. The features of local intensity roughness and variation were selected from the statistical and texture analysis. The accuracy, specificity, sensitivity, and AUC were 80.1%, 79.2%, 88.9%, and 0.84 for our new method of multi-region radiomics analysis, respectively, which was improved from 60.8%, 64.6%, 53.8%, and 0.62 for whole-lung radiomics analysis. Conclusions The developed multi-region radiomics analysis can help predict grade 2 RP for NSCLC after definitive radiotherapy. The radiomics features in the median- and high-dose regions, and that of local intensity roughness and variation were important factors in predicting grade 2 RP.


Sign in / Sign up

Export Citation Format

Share Document